CCM
BLFS icon

Coldstream Capital Management’s BioLife Solutions BLFS Stock Holding History

Coldstream Capital Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14
Closed -$320 – 1407
2025
Q1 		$320 Buy
+14
New +$369 ﹤0.01% 3435

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Coldstream Capital Management's BLFS Position: Q2 2025 in Review

Coldstream Capital Management sold out of BioLife Solutions (BLFS) in Q2 2025, closing a stake of 14 shares — an estimated $320 sold.

Coldstream Capital Management first reported a position in BLFS in Q1 2025 and held it in 1 quarter. The position peaked at $320 in Q1 2025. 194 funds tracked by Wall St. Rank hold BLFS as of Q2 2025.

  • Coldstream Capital Management reported no remaining BioLife Solutions position as of Q2 2025 after selling out during the quarter.
  • Coldstream Capital Management sold 14 BioLife Solutions shares in Q2 2025, an estimated $320.
  • Coldstream Capital Management first reported a position in BioLife Solutions in Q1 2025 and held it in 1 quarter.
  • Coldstream Capital Management's BioLife Solutions position peaked at $320 in Q1 2025.
  • 194 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.